Clinical Trial Update: Endurant Evo US Clinical Trial [NA]

View source ↗

Summary

Clinical trial update for Endurant Evo US study was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• Endurant Evo

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Abdominal Aortic Aneurysm, AAA | NA | Status: TERMINATED | Results posted: 2022-12-06